Chemoradiation Improves OS for Elderly Patients With Head and Neck Cancers - OncLive

OncLive

Chemoradiation Improves OS for Elderly Patients With Head and Neck Cancers OncLive All patients examined in the study had stage III and IV tumors of the oropharynx, larynx, and hypopharynx. All tumors were either node positive T1-2 or T3-4, N0-3. The median age in the chemoradiation arm was 75 years (range, 71-90). In the radiation ... Study links health insurance status and head and neck cancer diagnoses, outcomesEurekAlert (press release) Uninsured and Medicaid Patients with Head and Neck Cancer More Likely to Present with Advanced Tumors ...Newswise (press release) all 73 news articles »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1UbEtRH
via IFTTT